Hey everyone. Looks like Gmail ended up truncating the newsletter despite my efforts to stay under the limit. You will need to click on the “View entire message” button at the end of the email if you use Gmail.
I will post the other 15 clinical trials in a couple days once everyone has had a chance to digest the current post.
So what do you all think? Which trials do you believe will be successful? Which will have the biggest impact? Let me know in the comments.
It was a great review of whats happening. Abit disapointed tho about the monequles themself, but hey, maby a few of them can be useful. The stemcell activator thats oral is intresting. Guiess more mtor inhibbitors thats more specific to tor1 is on part 2.
But the most intresting must be the new nad analouge. but been completly quiet. even tho they now know what analouge it is, and that it increase nad by 400 plus %. But still quiet. hmm
Hey everyone. Looks like Gmail ended up truncating the newsletter despite my efforts to stay under the limit. You will need to click on the “View entire message” button at the end of the email if you use Gmail.
I will post the other 15 clinical trials in a couple days once everyone has had a chance to digest the current post.
So what do you all think? Which trials do you believe will be successful? Which will have the biggest impact? Let me know in the comments.
Great overview! Where did you get all this information?
Clinicaltrials.gov + company websites + GoogleFu
No talk about the oral nad analouge that was as potent as IV !?
Stay tuned for Part 2.
It was a great review of whats happening. Abit disapointed tho about the monequles themself, but hey, maby a few of them can be useful. The stemcell activator thats oral is intresting. Guiess more mtor inhibbitors thats more specific to tor1 is on part 2.
But the most intresting must be the new nad analouge. but been completly quiet. even tho they now know what analouge it is, and that it increase nad by 400 plus %. But still quiet. hmm
/viktor